Financial Performance Overview

Religare Enterprises Limited reported consolidated net profit of ₹859.6 crores for FY26, a decrease from ₹1,251.9 crores in FY25, with basic earnings per share at ₹2.59. The company reported total comprehensive loss of ₹364.2 crores primarily due to negative other comprehensive income of ₹1,095.8 crores. Standalone performance showed a net loss of ₹337.95 crores. Total consolidated assets stood at ₹14,505.6 crores with investments of ₹11,203.5 crores and cash equivalents of ₹588.1 crores.

Corporate Developments and Ownership Changes

The Burman Group entities (M.B. Finmart, Puran Associates, VIC Enterprises, and Milky Investment) completed their open offer in February 2025, acquiring 25.16% stake and becoming promoters with effective control of 30.28% shareholding. This resulted in a significant change in control and governance structure. The Board approved a Scheme of Arrangement in February 2026 to demerge the financial services business to Religare Finvest Limited, pending regulatory and shareholder approvals.

Capital Raising and Corporate Actions

The company approved a preferential issue of 6.38 crore convertible warrants at ₹235 per warrant for aggregate consideration of ₹1,500 crores, receiving ₹374.99 crores as upfront payment. During FY26, the company allotted 19.86 lakh equity shares on warrant conversion and 2.51 lakh shares under ESOP schemes. The issued capital increased to ₹332.89 crores (33.29 crore shares). RBI continued its advisory to stop dividend payments since April 2019.

Regulatory and Compliance Matters

The company faced multiple regulatory challenges including SEBI show cause notice and SAT proceedings, warning letters for delayed disclosures, and financial penalties exceeding ₹4 lakhs for delayed filings. Religare Finvest Limited achieved a significant milestone with RBI withdrawing its Corrective Action Plan in July 2025, removing all lending restrictions imposed since January 2018. Care Health Insurance Limited faced IRDAI penalty of ₹100 lakhs regarding ESOPs granted to former chairperson.

Subsidiary Performance and Segment Analysis

Care Health Insurance reported net loss of ₹28.5 crores (FY25: profit ₹160.7 crores) with net assets of ₹2,570.1 crores. The insurance segment reported revenue of ₹7,969.1 crores with segment loss of ₹46.8 crores. Broking activities generated revenue of ₹313.8 crores with profit of ₹18.0 crores. Investment and financing activities contributed revenue of ₹161.0 crores with profit of ₹131.4 crores.

Corporate Governance and AGM Details

The company will hold its 42nd Annual General Meeting on September 24, 2026 via video conferencing. Key agenda items include adoption of FY26 financial statements, re-appointment of director Gurumurthy Ramanathan, and re-designation of Arjun Lamba as Managing Director. The company implemented remote e-voting through KFin Technologies with cut-off date of September 17, 2026 for shareholder eligibility. Shareholding pattern showed 30.27% promoter holding and 69.73% public holding with significant institutional investment.

Risk Factors and Future Outlook

The company continues to face multiple legal and regulatory challenges including SFIO investigation since February 2018, tax disputes aggregating ₹424.3 crores, and pending redemption of preference shares worth ₹840.3 crores. The proposed demerger of financial services business and ongoing capital raising initiatives aim to strengthen the company's position across health insurance, broking, MSME lending, and housing finance segments under the theme of 'Building Wealth. Protecting Health.'